SCHEMBL6559508

SCHEMBL6559508

CC(C)S(=O)(=O)N(C)C1CC(C)(C)Oc2ccc(C(=O)O)cc21

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TBXA2R P21731 1/20 0.35
TBXAS1 P24557 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
KCNE1 P15382 4/20 0.34
KCNQ1 P51787 4/20 0.34
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
RXRA P19793 1/20 0.33
KCNA5 P22460 1/20 0.33
CTSD P07339 1/20 0.32
BACE1 P56817 1/20 0.32
BACE2 Q9Y5Z0 1/20 0.32
SRD5A2 P31213 1/20 0.32
AKR1B1 P15121 1/20 0.32
KDM1A O60341 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561170 0.91 HTR1D (0.35) MEN1KMT2AKCNE1KCNQ1KCNA5
SCHEMBL6559826 0.89 SMN1; SMN2 (0.36) MEN1KMT2AALDH1A1MAPK1KCNA5
SCHEMBL6560005 0.87 KCNE1 (0.43) MEN1KMT2ATBXA2RTBXAS1TDP1
SCHEMBL6559550 0.86 MEN1 (0.37) MEN1KMT2ATBXA2RTBXAS1TDP1
SCHEMBL6558501 0.85 KCNE1 (0.45) MEN1KMT2ATBXA2RTBXAS1KCNE1
SCHEMBL6561024 0.81 KCNE1 (0.48) MEN1KMT2AKCNE1KCNQ1
SCHEMBL6559607 0.81 KCNE1 (0.47) MEN1KMT2ATBXA2RTBXAS1KCNE1
SCHEMBL6559500 0.80 NPSR1 (0.38) MEN1KMT2ATBXA2RTBXAS1TDP1
SCHEMBL6560808 0.78 KCNE1 (0.41) KCNE1KCNQ1KDM1A
SCHEMBL6558778 0.77 HTR1A (0.36) KCNE1KCNQ1KCNA5KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed